Ledipasvir
Overview
Ledipasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection. It works by inhibiting the HCV NS5A protein, which is essential for viral replication.
API suppliers (2)
Suppliers of Ledipasvir evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 2 holds a GMP certificate on record in the EU or UK registers
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- Lupin LimitedIndia GMP on record
Therapeutic areas
Do you supply Ledipasvir? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.